Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Milestone Pharmaceuticals Inc
MISTCurrent price
1.28 USD
+0.02 USD (+1.59%)
Last closed
1.16 USD
Company
www.milestonepharma.com
ISIN
CA59935V1076
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
67 226 040 USD
Yield for 12 month
-18.47 %
1Y
3Y
5Y
10Y
15Y
MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada. Address: 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+1 000 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
+1 000 000 USD
Current Quarter
–
Last Quarter
–
Key Figures MIST
1 year
3 years
5 years
10 years
EBITDA
-41 997 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-34.92 %
PEG Ratio
–
Return On Equity TTM
-277.55 %
Wall Street Target Price
5.00 USD
Revenue TTM
–
Book Value
0.20 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.67 USD
Diluted Eps TTM
-0.67 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MIST
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MIST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation MIST
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
81.44
Price Sales TTM
77.32
Enterprise Value EBITDA
-1.43
Price Book MRQ
5.11
Financials MIST
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MIST
For 52 weeks
0.63 USD
2.75 USD
50 Day MA
1.56 USD
Shares Short Prior Month
880 568
200 Day MA
1.65 USD
Short Ratio
0.58
Shares Short
2 561 518
Short Percent
4.84 %
BeatStart